Oramed Pharmaceuticals Inc.
Organization details
- Legal name
- Oramed Pharmaceuticals Inc.
- Former names
- Integrated Security Technologies, Inc. Iguana Ventures Ltd
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- New York
- Headquarters state / province
- New York
- Headquarters country
- Israel
- Fiscal year end
- December
- Ticker symbol
- ORMP
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001176309
- EIN
- 98-0376008
- Wikidata ID
- Q28760388
Board of directors
-
Arie Mayer · DirectorSince 2023
-
Benjamin Shapiro · DirectorSince 2023
-
Daniel Aghion · DirectorSince 2024
-
Leonard Sank · DirectorSince 2023
-
Miriam Kidron · Director · Chief Scientific OfficerSince 2023
-
Nadav Kidron · Director · President and CEOSince 2023
-
Yadin Rozov · DirectorSince 2023
-
Yehuda Reznick · DirectorSince 2024
Chief executives
Director election results
Annual meeting of September 15, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
66.4%
-
67.6%
-
72.6%
-
78.4%
-
78.6%
-
78.6%
Board connections
4 of this board's directors also sit on 5 other boards. 2 are in the same sector.
-
Lifeward Ltd. Same sectorvia Miriam Kidron, Nadav Kidron and Yehuda Reznick
-
Alpha Tau Medical Ltd. Same sectorvia Nadav Kidron
- via Yadin Rozov
- via Yadin Rozov
- via Nadav Kidron
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $1,167,404
- 4 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 1, 2026 | Avraham Gabay Officer (Chief Financial Officer) | Open-market sale | −20,000 | $4.51 | $90,200 |
| Oct 1, 2026 | Hexter Joshua Officer (COO & CBO) | Open-market sale | −30,000 | $4.51 | $135,330 |
| Sep 24, 2026 | Avraham Gabay Officer (Chief Financial Officer) | Grant or award | +209,291 | — | — |
| Sep 24, 2026 | Hexter Joshua Officer (COO & CBO) | Grant or award | +75,455 | — | — |
| Sep 24, 2026 | Nadav Kidron Director, Officer (President and CEO) | Grant or award | +349,497 | — | — |
| Sep 24, 2026 | Miriam Kidron Director, Officer (Chief Scientific Officer) | Grant or award | +208,125 | — | — |
| Sep 24, 2026 | Hexter Joshua Officer (COO & CBO) | Grant or award | +209,291 | — | — |
| Sep 24, 2026 | Nadav Kidron Director, Officer (President and CEO) | Grant or award | +368,765 | — | — |
| Sep 24, 2026 | Miriam Kidron Director, Officer (Chief Scientific Officer) | Grant or award | +209,291 | — | — |
| Jul 2, 2026 | Hexter Joshua Officer (COO & CBO) | Option exercise | +50,000 | $3.69 | $184,500 |
| Jul 1, 2026 | Avraham Gabay Officer (Chief Financial Officer) | Open-market sale | −73,360 | $4.51 | $330,854 |
| Jul 1, 2026 | Hexter Joshua Officer (COO & CBO) | Open-market sale | −137,000 | $4.46 | $611,020 |
| Mar 30, 2026 | Nadav Kidron Director, Officer (President and CEO) | Shares withheld for tax | −44,818 | $3.31 | $148,348 |
| Mar 30, 2026 | Miriam Kidron Director, Officer (Chief Scientific Officer) | Shares withheld for tax | −435,084 | $3.31 | $1,440,128 |
| Mar 17, 2026 | Miriam Kidron Director, Officer (Chief Scientific Officer) | Grant or award | +119,558 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Oramed Pharmaceuticals Inc.
Who is the CEO of Oramed Pharmaceuticals Inc.?
Nadav Kidron is Oramed Pharmaceuticals Inc.'s President and CEO.
How many directors are on Oramed Pharmaceuticals Inc.'s board?
Oramed Pharmaceuticals Inc.'s board has 8 directors: Arie Mayer, Benjamin Shapiro, Daniel Aghion, Leonard Sank, Miriam Kidron, Nadav Kidron, Yadin Rozov and Yehuda Reznick.
Are Oramed Pharmaceuticals Inc. insiders buying or selling shares?
Over the last 12 months, Oramed Pharmaceuticals Inc. insiders made no open-market purchases and sold $1.2 million of shares in 4 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="oramed-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.